InvestorsHub Logo
Post# of 4968997
Next 10
Followers 7
Posts 179
Boards Moderated 0
Alias Born 02/20/2013

Re: SymphonicDelight post# 3416353

Friday, 06/27/2014 2:14:55 AM

Friday, June 27, 2014 2:14:55 AM

Post# of 4968997
$GWPH I've consulted the tarot cards...
Forbes article from 3 hours ago.

http://www.forbes.com/sites/davidkroll/2014/06/26/gw-pharmaceuticals-closes-u-s-public-offering-cannabid-based-medicines-progress/

Here is an excerpt:

In a commentary led by NYU’s Orrin Devinsky, M.D., Ph.D., a global collection of investigators come to a consensus that CBD has been incompletely investigated clinically due to poor trial design (i.e., unclear dosing regimens, improper study group sizes). But with the compelling preclinical studies and patient and caregiver anecdotes, CBD is certainly worthy of rigorous clinical investigation. Those hawking non-pharmaceutical CBD products might be dismayed to learn that several of the authors are collaborators of GW Pharmaceuticals and/or conducting GW-supported drug trials.

It would be very foolish to short this imho.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.